Feature

Web-Based Treatments for Depression in HIV-Infected Individuals

Depression is a common comorbidity in people living with HIV, with lifetime prevalence estimates ranging from 22% to 61%.

HIV Seroconversion Despite PrEP Therapy

The study evaluated a cohort of 14 young black, men who have sex with men in Atlanta, Georgia, who had HIV seroconversion despite treatment with ...

The Effect of Chronic Pain on HIV Outcomes

Chronic pain is a frequent comorbidity in people living with HIV, with a 2014 systematic review finding a 54% point prevalence.

Mental Health Problems in Adolescents With HIV: Overview & Expert Interview

Adolescents infected with HIV have a greater risk for psychiatric hospitalizations compared with those not infected with HIV.

Dolutegravir Use During Pregnancy: What Are the Risks?

Early evidence of a heightened risk for birth defects with dolutegravir is concerning but remains to be fully established.

Focus on HIV-2 Infection: A Clinician Roundtable

Clinicians should be aware of the possibility of HIV-2 infection in their patients coming from endemic areas, especially West Africa.

What Is the Role of Palliative Care in the Current HIV Treatment Era?

Numerous barriers to palliative care in patients living with HIV have been identified.

Fear-Based Public Health Campaigns for HIV/AIDS Prevention: Efficacy and Ethics

Is fear the best method for educating the public about the risks of contracting HIV, or does it further stigmatize an already underserved population?

News Articles

Early Prednisone Reduces TB-Related Immune Reconstitution Inflammatory Syndrome in PLWHIV

Early Prednisone Reduces TB-Related Immune Reconstitution Inflammatory Syndrome in PLWHIV

Prednisone during the first month of ART for those with HIV leads to a lower incidence of tuberculosis-related immune reconstitution inflammatory syndrome.

Combination of Lamivudine and Dolutegravir Effective in Treating HIV-1

Combination of Lamivudine and Dolutegravir Effective in Treating HIV-1

Combination therapy of lamivudine plus dolutegravir has shown efficacy, safety, and tolerability in people with HIV-1 infection.

A New Pathway of HIV-2 Integrase Strand-Transfer Inhibitor Resistance

A New Pathway of HIV-2 Integrase Strand-Transfer Inhibitor Resistance

A new integrase inhibitors resistance pathway in HIV-2 infected patients has been identified rendering isolates that are highly resistant.

HPV Biomarkers Predict Risk for Anal Precancer in MSM and Who Have HIV

HPV Biomarkers Predict Risk for Anal Precancer in MSM and Who Have HIV

Among men who have HIV who also have sex with men, HPV-related biomarkers provide long-term risk stratification for anal precancers.

HIV Diagnosis Disparities in US-Born vs Non-US-Born Black Women

HIV Diagnosis Disparities in US-Born vs Non-US-Born Black Women

Although HIV diagnoses among Black women have declined since 2008, there are disparities between US-born and non-US-born Black women.